stocks logo

DWTX

Dogwood Therapeutics Inc
$
4.890
-0.002(-0.041%)1D
  • Overview
  • Forecast
  • Valuation
  • Earnings
Line
Line
|
Candle
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
4.9937
Open
4.800
VWAP
4.86
Vol
11.81K
Mkt Cap
9.35M
Low
4.760
Amount
57.33K
EV/EBITDA(TTM)
--
Total Shares
1.91M
EV
92.47M
EV/OCF(TTM)
--
P/S(TTM)
--
Dogwood Therapeutics, Inc. is a development-stage biopharmaceutical company focused on developing new medicines to treat pain and fatigue-related disorders. The Company’s research pipeline includes two separate mechanistic platforms with a non-opioid analgesic program and an antiviral program. The proprietary, non-opioid, Nav 1.7 analgesic program is centered on its lead development candidate, Halneuron, which is a specific voltage-gated sodium channel modulator, a mechanism known to be effective for reducing pain transmission. In clinical studies, Halneuron treatment has demonstrated pain reduction in pain related to general cancer and in pain related to chronic chemotherapy-induced neuropathic pain (CINP). The Company’s antiviral program includes IMC-1 and IMC-2, which are fixed-dose combinations of nucleoside analog, anti-herpes antivirals and the anti-inflammatory agent celecoxib for the treatment of fibromyalgia (FM) and Long-COVID (LC).
Show More
2 Analyst Rating
up Image
309.00% Upside
Wall Street analysts forecast DWTX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for DWTX is 20.00 USD with a low forecast of 10.00 USD and a high forecast of 30.00  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
0 Hold
0 Sell
Moderate Buy
up Image
309.00% Upside
Current: 4.890
sliders
Low
10.00
Averages
20.00
High
30.00
HC Wainwright & Co.
Sean Lee
Hold
to
Strong Buy
Upgrades
$10
2025-04-23
Reason

Valuation Metrics

The current forward P/E ratio for Dogwood Therapeutics Inc (DWTX.O) is -0.84, compared to its 5-year average forward P/E of -2.18. For a more detailed relative valuation and DCF analysis to assess Dogwood Therapeutics Inc 's fair value, click here.

Forward PE

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-2.18
Current PE
-0.84
Overvalued PE
-0.75
Undervalued PE
-3.61

Forward EV/EBITDA

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00

Financials

Annual
Quarterly
FY2025Q1
0.00
Total Revenue
FY2025Q1
YoY :
+237.11%
-4.43M
Operating Profit
FY2025Q1
YoY :
+746.02%
-10.92M
Net Income after Tax
FY2025Q1
YoY :
+402.98%
-8.45
EPS - Diluted

Trading Trends

Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months

DWTX News & Events

Events Timeline

2025-05-08 (ET)
2025-05-08
09:02:57
Dogwood sees cash runway through 1Q26
select
2025-05-08
09:02:16
Dogwood reports Q1 EPS ($8.45) vs. ($1.68) last year
select
2025-04-11 (ET)
2025-04-11
09:21:50
Dogwood receives Nasdaq confirmation of compliance
select
Sign Up For More Events

News

9.0
08-07Newsfilter
PinnedDogwood Therapeutics Announces Enrollment of First Fifty Patients in Ongoing Halneuron® Phase 2b Trial
1.0
06-03Newsfilter
Dogwood Therapeutics to Present at Sidoti Small-Cap Virtual Conference
4.0
04-23Benzinga
HC Wainwright & Co. Upgrades Dogwood Therapeutics to Buy, Announces $10 Price Target
Sign Up For More News

FAQ

arrow icon

What is Dogwood Therapeutics Inc (DWTX) stock price today?

The current price of DWTX is 4.89 USD — it has decreased -0.04 % in the last trading day.

arrow icon

What is Dogwood Therapeutics Inc (DWTX)'s business?

arrow icon

What is the price predicton of DWTX Stock?

arrow icon

What is Dogwood Therapeutics Inc (DWTX)'s revenue for the last quarter?

arrow icon

What is Dogwood Therapeutics Inc (DWTX)'s earnings per share (EPS) for the last quarter?

arrow icon

What changes have occurred in the market's expectations for Dogwood Therapeutics Inc (DWTX)'s fundamentals?

arrow icon

How many employees does Dogwood Therapeutics Inc (DWTX). have?

arrow icon

What is Dogwood Therapeutics Inc (DWTX) market cap?